Japanese biotech firm Rakuten Medical wants to bring its novel ‘lightsaber’ cancer cure to the U.S.

The Quick Take
In the short-term, the firm is looking to enter markets close to home—including Taiwan, Macau, Singapore, Hong Kong and Saudi Arabia.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to Fortune.



